Navigation Links
3M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections
Date:6/16/2008

ST. PAUL, Minn. and SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- 3M and Gen-Probe Incorporated (Nasdaq: GPRO) announced today that 3M has discontinued the companies' collaboration to develop rapid molecular tests for healthcare-associated infections (HCAIs).

The companies, which are exploring the possibility of a future marketing collaboration in this area, said the collaboration was discontinued due to current technical incompatibilities between Gen-Probe's nucleic acid testing technologies and 3M's proprietary microfluidics instrument platform.

"We intend to evaluate the merits of developing molecular tests for HCAIs to run on our next-generation automated instruments," said Steve Kondor, Gen-Probe's senior vice president of sales and marketing. "This approach, if successful, could help us develop products more rapidly, while further establishing our instrument platforms among current and future low- to mid-volume customers."

3M reaffirmed its commitment to developing and delivering products and solutions for the issues associated with HCAIs. "Our technology platforms are helping hospitals address the important issue of HCAIs," said Chuck Kummeth, vice president and general manager, 3M Medical Division. "We'll continue to offer our customers solutions that detect, prevent and control infections."

Under the terms of the discontinued agreement, Gen-Probe was responsible for assay development, which 3M funded. 3M also agreed to pay milestones to Gen-Probe based on technical and commercial progress. Gen-Probe earned the first of these milestones in the fourth quarter of 2007.

About 3M Health Care

Since inventing Ioban Antimicrobial Incise Surgical Drapes more than 30 years ago, 3M has been a worldwi
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents
2. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
3. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
4. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
5. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
6. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
7. SGX Provides Update on BCR-ABL Collaboration
8. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
9. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
10. Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement
11. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...if., Nov. 6 ,, 3Q0...r of Qutenza(TM) E.U. Marketing Authorization to A...ress in commercial readiness activities Expanded ...or, Marketing; and Director, Commercial Operations...or and Audit Committee chairman , Upcoming ...
(Date:11/6/2009)...6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc....any") today announced updated results from a Phase...ith sarcomas metastatic to the lung in a poster pr...cology Society Meeting held in Miami Beach, Florid...on, entitled "A Phase II Study of Intravenous REOL...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Person...set to take place on February 22-24, 2010 in Phila...ference we will highlight key issues in forming pa...heir experiences. , Minne...for Arrowhead’s 2010 Personalized Medicine ...
(Date:11/5/2009)...Md., Nov. 5 GenVec, Inc....sults for the third quarter ended September 30, 20....04 per share) for the three months ended Septembe...($0.08 per share) in the comparable quarter of 200...enVec,s net loss was $14.1 million ($0.15 per shar...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... Multiporator / Electroporator 2510 , , ,... Transformation Protocol , P... , , , , , , , ,..., Kluyveromyces lactis AWJ137, ,...ast, , , Molecules ...
... Multiporator / Electroporator 2510 , , ,... Transformation Protocol , P... , , , , , , , ,..., Escherichia coli C600, , ..., gram negative, , , ...
... Multiporator / Electroporator 2510 , , ,... Transformation Protocol , ,... , , , , , ,... , Microorganism , Azotobac... Cell type , Bacteria, gram negative,...
Other Biology Technology:Kluyveromyces lactis 2Escherichia coli C600 2Escherichia coli C600 3Azotobacter vinelandii 2
(Date:11/6/2009)..., FAIRFAX, Va.Registration is now open for the So...Interventional Oncology (IO) Therapies" Webinar, w...us and transcatheter treatment of liver tumors, ki...s a national organization of physicians, scientist...roving public health through pioneering advances i...
(Date:11/5/2009)..., The National Association of Biology Teachers (N...r of biological sciences at Naugatuck Valley Commu...h the 2009 Evolution Education Award during the NA...e held 11-14 November 2009 in Denver, Colorado. ,...the American Institute of Biological Sciences,(AI...
(Date:11/4/2009)..., Heavy traffic corridors in the cities of Long B...nt proportion of preventable childhood asthma, and...ns on the disease has likely been underestimated, ...hern California (USC). , The study, which appea...f Public Health , estimated that nine percent of a...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2Biologists, educators recognize excellence in evolution education 2USC study finds big air pollution impacts on local communities 2Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 1Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 2Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 3Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 4Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 5Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 6Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 7Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 8Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 9Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 10Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 11Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 12Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 13Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 14Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 15Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 16Reportlinker Adds the Dental Market 3A Techniques Equipment and Materials Report 56181 17Reportlinker Adds Markets for Advanced Wound Care Technologies Report 56177 1Reportlinker Adds Markets for Advanced Wound Care Technologies Report 56177 2Reportlinker Adds Markets for Advanced Wound Care Technologies Report 56177 3Reportlinker Adds Markets for Advanced Wound Care Technologies Report 56177 4Reportlinker Adds Markets for Advanced Wound Care Technologies Report 56177 5Reportlinker Adds Markets for Advanced Wound Care Technologies Report 56177 6Reportlinker Adds Markets for Advanced Wound Care Technologies Report 56177 7Reportlinker Adds Markets for Advanced Wound Care Technologies Report 56177 8Reportlinker Adds Markets for Advanced Wound Care Technologies Report 56177 9Reportlinker Adds Markets for Advanced Wound Care Technologies Report 56177 10A Safety Slip 3A Dont Hold a Child in Your Lap on Playground Slides 56173 1A Safety Slip 3A Dont Hold a Child in Your Lap on Playground Slides 56173 2
...study provides insight into a calcium-sensing enzy...beats and other critical functions. The researcher...M kinase II), contributes to arrhythmia in an extr...t inhibiting the enzyme prevents irregular heartbe...ar model, could help with developing treatments fo...
... The University of Queensland could contribute to ...e virus and Dengue fever. , Led by Associate Pro...rom UQ,s School of Molecular and Microbial Science...amily to which these diseases belong. , The team...which, among other functions, controlled the host,...
....Y. Much like cancer cells, plant cells grown for...lture dishes, have highly unstable genomes. Change...help cells cope with challenging culture condition...regulation by transposons -- bits of DNA that can ...to random genetic locations, often disrupting norm...
Other Biology News:Rare disease provides clues about enzyme role in arrhythmias 2Rare disease provides clues about enzyme role in arrhythmias 3UQ research targets West Nile virus and dengue fever 2CSHL researchers map changing epigenetic modifications that enable transposons to run amok 2
EZ-Chip from Upstate
...or the PDS-1000 He biolistic system enables 7-10 t...d system. It fits into the shocking chamber of the...ock wave over 7 microcarriers. By uniformly spread... this larger area, the system maximizes the number...
Acetyl-Histone H3 Immunoprecipitation (ChIP) Assay Kit from Upstate
...itochondrial transmembrane potential is one of the...g induction of apoptosis. The MitoLight Apoptosis...d as MitoLight, as a mitochondrial activity marker...ochondria in living cells in a membrane potential-...
Biology Products: